Compare Simon Property Group Inc (SPG) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Simon Property Group Inc vs Viatris Inc — how do they compare? Simon Property Group Inc trades at $206.11 (market cap $66.18B), while Viatris Inc trades at $16.45 (market cap $18.95B). The key difference: Simon Property Group Inc is far larger — about 3.5× Viatris Inc's market cap, and Simon Property Group Inc pays the higher dividend (4.35%). Which is the better fit depends on your goals.
| SPG | VTRS | |
|---|---|---|
Market Cap | $66.18B | $18.95B |
Sector | Real Estate | Health |
52-Week High | $236.70 | $17.86 |
52-Week Low | $173.35 | $9.49 |
Enterprise Value | $94.63B | $31.07B |
Dividend Yield | 4.35% | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPG trades at $211.88, up 1.17% on the day, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a Q2 2026 revenue increase of 19.3% and a net income margin of 66.57%, supported by a P/E of 14.95. Recent news includes a $800 million senior notes issuance and the launch of Simon Media Network to monetize mall traffic.
The outlook is mixed; analyst consensus targets $231.82 with 42% buy ratings, but technical indicators suggest near-term pressure. Key risks include high leverage with $24.21B long-term debt and sensitivity to retail real estate cycles. Upside potential hinges on continued leasing strength and effective new media initiatives.
Viatris (VTRS) trades at $16.61, down 1.6% on the day, with a bullish technical signal but mixed moving averages. The company reported Q2 2026 EPS of $0.69, beating estimates, and revenue growth of 5% year-over-year. Despite negative net income margins, strong cash flow generation supports dividends and buybacks. Recent news highlights pipeline progress and a higher 2026 outlook.
Outlook: Viatris shows operational strength with consistent earnings beats and cash flow, but high P/E and negative profitability pose risks. Investment opportunity lies in deleveraging and pipeline advancements, while headwinds include generic drug pricing pressure and regulatory uncertainty. Analyst sentiment is mixed with a hold-heavy consensus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
